Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials

INTRODUCTION: This meta-analysis of data from 14 phase 2 and 3, double-blind, randomized, controlled 12- and 24-week studies (N = 4632) summarizes saxagliptin efficacy in patients with type 2 diabetes (T2D) across treatment regimens. METHODS: Patients received saxagliptin 5 mg/d or control as either...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Ther
Päätekijät: Sjöstrand, Mikaela, Wei, Cheryl, Cook, William, Johnsson, Kristina, Pollack, Pia S., Stahre, Christina, Hirshberg, Boaz
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Healthcare 2017
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5446386/
https://ncbi.nlm.nih.gov/pubmed/28432619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0261-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia